chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have a plate in my right knee and bi lateral artificial knees .  I have noticeable soreness in right plate and knee area that occurred within 24 hours of vaccine.  Some slight swelling as well
Traveling tingling throughout body. Tested for all other effects. No treatment, waiting for it to go away.
A few minutes after receiving Dose 1 of Pfizer Covid vaccine, pt started showing signs of fainting. She had cold sweats, hot, pale, and anxious. The emergency number was called. By the time the EMTs arrived she was getting better. EMTs assessed her and all was normal but when they done a finger stick to check her blood pressure the patient started exhibiting the same signs. We the monitored her again for 20 to 30 minutes and she regained color and everything resolved and she walked out on her one with her mother.
This spontaneous report was received from a physician referring to a 2-year-old patient of unknown gender. Pertinent medical history or concurrent conditions were not reported. On 09-AUG-2017, the patient was vaccinated with improperly stored dose of VAQTA (lot # N005274, expiration date 03-APR-2018) (dosage information and route were not informed). Information regarding concomitant medication was not provided. Additionally, it was reported that the lowest temperature was 32°F and the higher was 54°F for 70 hours. Data logger was not involved. No adverse effects were reported. There was no product quality complaint involved. This is one of several cases from the same reporter. Sender's Comments: US-009507513-1709USA007325: US-009507513-1709USA012768.
This spontaneous report was received from a registered nurse and refers to unspecified number of patients of unknown age and gender. No information about patients' medical history, concurrent conditions and concomitant medications was provided. On unknown dates in the past, the patients were vaccinated with doses of GARDASIL 9 (dose, route of administration and site of vaccination, lot number and expiration date were not reported). On unknown dates, the patients experienced syncope. The outcome of syncope was reported as recovered on unknown dates for all patients. The relatedness between the event and GARDASIL 9 was not reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA003795: US-009507513-1611USA007576.
On 4/27/01, pt developed achiness in all joints that persisted for approximately 3 weeks. On 5/26/01, the achiness returned and persisted for 2-3 weeks. From 6/25/01 until the date of report, the achiness has persisted for approximately 60% of the time. On the date of report, pt had a lot of pain in jaws, elbows and wrists.
This spontaneous report was received from a physician via company representative concerning a 1 day old male baby. Pertinent medical history, concurrent conditions, concomitant medications and allergies  regarding the baby were not provided. In APR-2018, the patient was inadvertently vaccinated with M-M-R II for prophylaxis (strength, dose, route, dosage schedule, anatomical location, lot # and expiry date were not provided) instead of hepatitis B vaccine (manufacturer unknown) (strength, dose, frequency, route, lot #, and expiration date were not provided) for prophylaxis (wrong drug administered; drug administered to patient of inappropriate age). The physician reported that after the hospital realized the baby got the wrong vaccine they decided to keep the baby in the hospital for a longer time as a precautionary measure to monitor the patient. Also, as precaution, the hospital arranged for the baby's parents to consult with staff neurologist and infectious disease specialist before they let the baby to leave the hospital and go home with his parents. It was mentioned that, at the day of reporting, the baby had a follow up visit with the reporting physician. The hospital duration was unspecified. No adverse reaction reported. Upon internal review, the wrong drug administered and drug administered to patient of inappropriate age were considered to be serious due to hospitalization.
Sore arm after the injection for less than 24 hours.  No problems other than sore arm after the first and second Moderna CoVid 19 vaccinations.  On Day 12 after receiving the vaccine (Moderna Booster), had whole body itchiness and hive formation upon scratching.  Urticarial and Dermatographia reactions.  Hives last for less than 1 hour upon taking Benadryl.  Then hours later or the next day, they show up again in a different location.  I have had them in groin, legs, arms, chest, and back. I am now taking Zyrtec each morning and this seems to keep the hives away for the most part.  If they show up I take Benadryl.  If I skip Zyrtec, the hives will show up within 24 hours.
Narrative:  COVID infection following COVID vaccine series 01/27 Pfizer, dose #1 02/17, Pfizer, dose #2 04/16 Nasal PCR COVID not detected 04/16 NASAL PCR FLU A, FLU B, RSV: result: negative 08/03 pt cc: cough, fatigue, dyspnea exposure: unknown 08/12- 08/18 pt Pt symptoms continue 08/13 pt admitted to non agency ED dx: COVID PNEUMONIA, LOS: unknown 08/11 COVID swab, result: detected 08/11 SARS-COV-2 Variant Sequencing result: pending 08/19 clinically resolved
Nail fungus on all 10 of my fingernails.; This is a spontaneous report from a contactable healthcare professional (patient).  A 42-years-old (also the age at time of vaccination) non-pregnant (also at the time of vaccination) female patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 14Apr2021 09:00 (also reported as 12Apr2021 09:30 -pending clarification) (Batch/Lot Number: EW0150) as DOSE 1, SINGLE for COVID-19 immunization.  Medical history included Severe nerve damage since 30Jun2013 and ongoing due to car accident with tanium rod pelvic on unknown date, and ongoing anxiety. Family medical history included high blood pressure and diabetes. Concomitant medications included pregabalin (LYRICA) taken for nerve injury from 06Apr2021 and ongoing, escitalopram oxalate (LEXAPRO) taken for anxiety from Jun2013 and ongoing and nature bounty hair , nails, skin v.  On 26Apr2021, the patient had nail fungus on all 10 of her fingernails. She mentioned that it started when she noticed that her nails flipping up and very brittle and hard looking. The nail had lifted from the nail bed. The event required visit to physician office and received (Brand name unspecified) with terbinafine, oral meds, and droplets for nails. Prior to vaccination, the patient was not diagnosed with COVID-19.  It was stated that the patient had been tested for COVID-19 since vaccination (unknown results). As of 06Aug2021, the patient was still taking medications per doctor. The physician also mentioned that it won't completely grow out until 9 months. Outcome of the event was not recovered. The patient received the 2nd dose of bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE) on 03May2021 09:00 am administered in Arm Right (Batch/ Lot number: EW0170) for COVID-19 immunization. The reporter consider that the Pfizer product had a causal effect to the adverse event. Follow-up attempts are completed. No further information is expected.
Pt's face looked pale after the shots. She complained of a little dizziness. No sob, no rash. No difficulty in breathing. Nurse assisted to lie down on the table with legs elevated. HR 53 bpm, BP 110/66, SpO2 94 initially. About 1min later, SpO2 to 98, HR 58. Pt's dizziness went away in about 2-3mins. Recheck HR 5 mins later, HR 70. Pt acted fine and looked fine. No dizziness. Pt went home together with her mom.
sore arm; very sleepy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) and SOMNOLENCE (very sleepy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm) and SOMNOLENCE (very sleepy). At the time of the report, VACCINATION SITE PAIN (sore arm) and SOMNOLENCE (very sleepy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
He was given the Covid vaccine at a pharmacy and not at my office. 4 days after the vaccine he noticed discomfort in the right calf.  Initially he dismissed it but then gradually the calf started to swell.  Once he noticed some shortness of breath he decided to come into the office.  He was seen on 4/12/21 and diagnosed with a pulmonary embolism.  He was then admitted to Hospital for IV therapy and monitoring.
DIARRHEA; This spontaneous report received from a patient concerned an 81 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient experienced drug allergy when treated with morphine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 14-APR-2021, the subject experienced diarrhea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea on 14-APR-2021. This report was non-serious.
Swelling in the face, jaw and lymph nodes; Swelling in the face, jaw and lymph nodes; This is a spontaneous report received from contactable reporter(s) (Nurse). Other Case identifier(s): 2022NVX-000004257 (Novavax).  A 75-year-old female patient received BNT162b2 (BNT162B2), in Feb2021 as dose 1, single (Batch/Lot number: unknown) at the age of 74 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SWELLING FACE (non-serious), LYMPHADENOPATHY (non-serious), outcome "unknown" and all described as "Swelling in the face, jaw and lymph nodes".  Additional information: It was also reported that on 17Nov2022, it was reported that a patient started treatment on an unspecified date in Feb2021 with Pfizer BioNTech COVID-19 Vaccine (tozinameran) at dose 1 and dose 2 for COVID-19 immunisation. It was reported that the patient had swelling in the face, jaw and lymph nodes.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient was vaccinated with first dose of Pfizer vaccine within the pharmacy lobby of clinic then fainted seconds later. He was caught by staff member and transferred to a chair with the assistance of father and staff member; the patient was noted to have involuntary shaking of extremities. Rapid response was alerted.  Patient regained consciousness within a minute and informed staff that he started feeling lightheaded immediately after receiving shot.  Episode was witnessed by father and two pharmacy staff members.  Patient was transfered to clinic, then discharged with an appointment set up with a cardiovascular doctor at the hospital to follow up on previously known heart murmur.
c/o Pain in left shoulder radiating up neck. 11/12- Saw private physician who diagnosed neck sprain from ? gym equipment.
This case was reported by a healthcare professional and described the occurrence of weakness in arms and legs in a 22-year-old female subject who was vaccinated with ENGERIX B (GlaxoSmithKline). There were no concurrent medications or relevant medical history. On an unspecified date, the subject received 4th dose of ENGERIX B. On 1 September 2010 at 14:00 the subject received 5th dose of ENGERIX B (unknown, left arm). With both the 4th and 5th doses of ENGERIX B, the subject experienced extra dose administered. Less than one year after vaccination with 5th dose of ENGERIX B, the subject experienced weakness in her left leg and arm, tingling in her left hand and foot, and cramping and twitching in her left calf. The subject reported that she received a fourth and fifth injection because her physician wanted her titer to be higher, even though it was still within normal limits. The healthcare professional considered the events were disabling. At the time of reporting the events were unresolved.
Given MMR and Varicella left leg/thigh on 4-16-07. Next day had left leg, red, raised, rash, swollen, hot from upper thigh down to knee. Mother informed to ice/cold compress take Tylenol or Motrin appt on 1/18/07 to f/u. Little better taking Tylenol able to walk.
01/28 Developed a cough and progressed after about a week to an aggressive cough. After about 2 weeks contact doctor for a wheezing cough and congestion. Contacted thru telehealth and was advised to come in for chest x-rays. It came back clear and was given Albuterol inhaler, Symbicort inhaler, and was told to continue with OTC regimen (Dayquil, Robitussin DM) Also, was advised to come back if continues. Since then, my cough seems to be waning and I still have a small cough issue.
Information has been received from a physician concerning a 16 year old female who on 31-MAR-2008 was vaccinated with a first dose of GARDASIL (route and administration site not reported). The patient was healthy prior to her second dose of GARDASIL. On 05-JUN-2008 the patient was vaccinated with a second dose of GARDASIL (route and administration site not reported). On 05-JUN-2008 the patient experienced severe fatigue, shortness of breath and chest discomfort. She was seen in urgent care sometime between June 5th and 9th. She was treated with an inhaler. On 09-JUN-2008 she followed-up with her physician. Her chest X-ray showed bronchitis. She was prescribed MEDROL DOSEPAK and albuterol as needed. The patient was referred to a pulmonologist and an allergist. She saw the allergist on 11-JUN-2008, the allergist agreed that the patient had bronchitis. He treated her with Z-PAK and albuterol, then added CLARINEX, "Cymbicort" and prednisone (manufacturer unknown) 40 mg. The patient was followed-up on 17-JUN-2008 with her primary care physician and she diagnosed her with dyspnea. Another follow up visit was made on 05-AUG-2008, her shortness of breath was resolved, but she still complained of severe fatigue. Her blood work showed reactivation of Epstein-Barr Virus. A follow up visit was made on 25-AUG-2008 she still complained of chronic fatigue. Additional information has been requested.
Red, swollen area approximately 1.5cm in diameter, multiple areas on left and right legs.  Patient's mom called in adverse reaction 7 days after vaccines were administered.  Cold compresses and use Tylenol and Benadryl were instructed for treatment.
Two days after first vaccine set, vomiting prompted ER evaluation, and abdominal film read as possible intussusception, which spontaneously resolved after transfer to higher-level facility.
Moderate to severe fatigue; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 09:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar 2. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lamotrigine (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 11:00, the patient experienced moderate to severe fatigue. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event moderate to severe fatigue was resolved on an unknown date in Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained.
At approximately 6 hours after receiving vaccine, I experienced extreme bilateral ear pressure and hearing loss.  Similar experience to flying, ear plugging.  It relieved after about 1 hour.  Never a popping feeling or anything remarkable.  Just as if the pressure relieved.
Muscle aches, a rash covering body per patient's spouse, and low white blood cell count, low platelet count per doctor's office.
G2P2 prior to vaccination. Two prior uncomplicated pregnancies- both infants born at term by SVD without any complications; born 09/2019 and 01/2018. No prior history of miscarriage. Following injection, experienced a missed miscarriage at 12w5d despite normal genetic testing; then a second missed miscarriage at 10w3d.
Pt received Moderna vaccine at approx 0930. Pt stated began "feeling funny" with feeling of increased heart rate approx 20 minutes after vaccine administration, but thought it might just be anxiety. Pt waited 5 more minutes, then states her symptoms continued to get worse. Pt notified staff at this point that she was not feeling well and nurse immediately responded. upon arrival to pt, pt informed nurse that she was experiencing tachycardia and felt like her chest was tight. While nurse was assessing pt, pt then stated she felt like her throat was starting to feel tight, as well. Pt stated she had hx of asthma and carries inahler. Pt took puff of inhaler while nurse injected pt with 50mg of IM Benadryl into her L deltoid. Benadryl administered at 0956. Nurse stayed with pt. Over the next few minutes pt stated her heart rate began to normalize. Stated her chest and throat tightness were getting better. Pt waited 30 more minutes before leaving the building.  Pt stated that prior to leaving her s/s had resolved. states she did not feel drowsy at all from the Benadryl. Encouraged pt to have someone pick her up from the site instead of driving home. Pt stated she felt well enough to drive herself home and experience no drowsiness from the Benadryl. Nurse called pt 2 days after vaccine administration. pt states was feeling completely back to normal now. states after returning home, later in the afternoon she still felt like her breathing wasn't as good as normal. Pt used her prescribed nebulizer treatment at home and experienced instant relief. no recurrence of any s/s after that.
Confusion, Dizziness, Myalgia, Tachypnea, CoughWheeze, Diarrhea &  HYPOtension Narrative:  severe diarrhea, sob, fatigue, cough feeling unwell, dizzy, hypotension, fainted- found to have pneumonia placed on antibiotics, stool cultures- lost many days from work- ct of chest pending - under PCP care  Other Relevant History:
Approximately 2-3 weeks following vaccination, I began to experience debilitating leg pain, the severity of which increased to the point where I couldn't stand or walk longer than about 5 minutes. An x-ray and MRIs disclosed arthritis in my lower back. When other remedies didn't work, the neurologist prescribed steroids. However before I received the steroids, the pain quickly and completely went away. I believe the vaccine inflamed my pre-existing arthritis, then went away when the vaccine poison finally dissipated. That was three months ago and the pain hasn't returned. A good friend had a similar experience.
severe arm pain on arm of injection - limited movement and difficulty sleeping due to pain. Sever for 2 days, then just sore. After 9 days severe pain returned for 2 days. Now at 14 days am still sore but most range of motion is returning. Have treated with ice and advil but concerned that I won't be healed before vaccine #2.
Information has been received from a nurse concerning a 19 year old female patient who is the daughter of one of the office employees, who on 02-Nov-2006 was vaccinated with the first dose of HPV rL1 6 11 16 18 VLP vaccine (yeast) (Lot#653650/0696F). Concomitant therapy included hormonal contraceptives (unspecified). On 02-Nov-2006 the patient developed nausea, low grade fever, achiness and a headache post vaccination. It was reported that these events continued into the evening on 02-Nov-2006. On 03-Nov-2006, the next morning the patient had recovered from all of the events. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 12/14/2006.  Information has been received from a nurse concerning a 19 year old female patient who is the daughter of one of the office employees, who on 02-NOV-2006 was vaccinated with the first dose of GARDASIL (Lot # 653650/0696F).  Concomitant therapy included hormonal contraceptives (unspecified).  On 02-NOV-2006 the patient developed nausea, dizziness, low grade fever, achiness and a headache post vaccination.  It was reported that these events continued into the evening on 02-NOV-2006.  On 03-NOV-2006, the next morning the patient had recovered from all of the events.  Additional information has been requested.
Vaccine given on 9/27/00 and reported to EH on 10/2/00, that starting, 1 day post vax, the area around the injection site became firm to touch, swollen, reddened and painful. Symptoms still persist. Pt had some kind of accident at work to her right upper arm.
neurological issues; Information has been received from a lawyer regarding a case in litigation referring to a patient (pt) of unknown age and gender. Information about concurrent condition, medical history and concomitant medication was not reported. On or about 15-FEB-2016 (at approximately 64 years old), the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot#, expiration date and route unknown) for the long-term prevention of shingles and zoster-related conditions. Subsequently, the pt was treated by providers for the following injuries resulting from zoster vaccine live (ZOSTAVAX) use: neurological issues. The outcome of the event was unknown.
had shingles for years, and had the shots./ suspected vaccination failure; had shingles for years,; red spot; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and localized erythema. On an unknown date, the outcome of the vaccination failure, shingles and localized erythema were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and localized erythema to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient. The age at vaccination was not reported. The patient received the shots and had shingles for years. The patient guess that he/she had been lucky. All that the patient ever get was a 2-inch red spot on butt for a week every year. This case was considered to be a suspected vaccination failure case, as the details regarding laboratory confirmation for shingles and time to onset were unknown.